Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $10.8650 (-0.09%) ($10.8650 - $11.0450) on Tue. Oct. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 36 | Latest Price | $10.8650(-0.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -0.3% a day on average for past five trading days. | Weekly Trend | FOLD declines -5.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(75%) IBB(69%) ARKG(63%) IWO(56%) JNK(55%) | Factors Impacting FOLD price | FOLD will decline at least -1.43% in a week (0% probabilities). TBT(-41%) EDOC(-27%) UUP(-23%) VXX(-16%) VIXM(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-2.23(-120.52%) | Resistance Level | $11.92 | 5 Day Moving Average | $10.95(-0.78%) | 10 Day Moving Average | $11.32(-4.02%) | 20 Day Moving Average | $11.92(-8.85%) | To recent high | -21.2% | To recent low | 0.6% | Market Cap | $2.806b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |